首页> 外文OA文献 >Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study

【2h】

Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study

机译：通过改变生存素反义寡核苷酸LY2181308的肿瘤大小与多西他赛联合用于非小细胞肺癌患者的二线治疗，评估抗肿瘤活性：一项开放标签II期随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Natale Ronald; Blackhall Fiona; Kowalski Dariusz; Ramlau Rodryg; Bepler Gerold; Grossi Francesco; Lerchenmüller Christian; Pinder-Schenck Mary; Mezger Jörg; Danson Sarah; Gadgeel Shirish M.; Summers Yvonne; Callies Sophie; André Valérie; Das Mayukh; Lahn Michael; Talbot Denis;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non-Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study. [J] . Ronald Natale, Fiona Blackhall, Dariusz Kowalski, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2014,第11期

机译：使用Survivin反义寡核苷酸Ly2181308的肿瘤大小的变化评价抗肿瘤性能与多种小细胞肺癌患者的二线治疗组合的多西紫杉醇：随机开放标签II研究。
3. Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non-Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study. [J] . Ronald Natale, Fiona Blackhall, Dariusz Kowalski, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2014,第11期

机译：使用Survivin反义寡核苷酸LY2181308的肿瘤大小变化与多西紫杉醇联合用于非小细胞肺癌患者二线治疗的抗肿瘤活性评估：随机开放标签II期研究。
4. EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer. [J] . J V Heymach, S J Lockwood, R S Herbst, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第10期

机译：在一项晚期非小细胞肺癌患者二线治疗的随机III期研究中，EGFR生物标记物预测了Vandetanib与docetaxel联用的益处。
5. PHASE II OPEN-LABEL STUDY OF SINGLE-AGENT HYDROXYUREA FOR TREATMENT OF ADVANCED CUTANEOUS MAST CELL TUMORS IN DOGS [C] . Ken Rassnick, Renee Al-Sarraf, Dennis Bailey, Annual Conference of the Veterinary Cancer Society . 2009

机译：单药羟基脲的第II期开放标签研究，用于治疗犬晚皮腰肿瘤瘤
6. Structure--activity relationship studies of hybrid antitumor agents for the treatment of non-small cell lung cancer. [D] . Ma, Zhidong. 2009

机译：杂合抗肿瘤药治疗非小细胞肺癌的构效关系研究。
7. Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer [O] . Ronald Natale, Fiona Blackhall, Dariusz Kowalski, -1

机译：通过改变生存素反义寡核苷酸LY2181308的肿瘤大小与多西他赛联合用于非小细胞肺癌患者的二线治疗评估抗肿瘤活性
8. Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study. [O] . Natale, Ronald, Blackhall, Fiona, Kowalski, Dariusz, 2014

机译：使用存活蛋白反义寡核苷酸LY2181308与多西紫杉醇联合用于非小细胞肺癌患者的二线治疗的肿瘤大小的变化来评价抗肿瘤活性：随机化的开放标记II期研究。

Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study

著录项

引文网络

相似文献

相关主题

期刊订阅